Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 1, 1997, Pages 1-6

  Gebhardt, Rolf ^a   Beckers, Gerhard ^a   Gaunitz, Frank ^a   Haupt, Wolfram ^a   Jonitza, Dirk ^a   Klein, Sabine ^a   Scheja, Ludger ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ARGININE; CARBAMOYL PHOSPHATE SYNTHASE; CARBON TETRACHLORIDE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; ORNITHINE ASPARTATE;

AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; HYPERAMMONEMIA; LIVER CELL CULTURE; LIVER CIRRHOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; UREA CYCLE;

AMINO ACIDS; AMMONIA; ANIMALS; CARBON TETRACHLORIDE; DIPEPTIDES; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; RATS; UREA;

EID: 0030803169     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. CONN, O. H.: The theoretic therapy of hepatic encephalopathy. In Hepatic Encephalopathy: Syndromes and Therapies, ed. by H. O. Conn and J. Bircher, pp. 135-147, Medi-Ed. Press., Bloomington, IL, 1994.
2. COOPER, A. J. L., LAI, J. C. R. AND GELBARD, A. S.: Ammonia in liver and extrahepatic tissues: An overview of metabolism and toxicity in mammals. In Hepatic Encephalopathy: Pathophysiology and Treatment, ed. by R. F. Butterworth, G. Pomier Layrargues, pp. 27-48, Humana Press, Clifton, NJ, 1989.
3. 4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment. J. Hepatol. 12: 110-117, 1991.
4. GEBHARDT, R. AND MECKE, D.: Permissive effect of dexamethasone on glucagon induction of urea-cycle enzymes in perifused primary monolayer cultures of rat hepatocytes. Eur. J. Biochem. 97: 29-35, 1979.
5. GEBHARDT, R. AND REICHEN, J.: Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: potential role in hyperammonemia. Hepatology 20: 684-691, 1994.
6. GEBHARDT, R. AND WILLLIAMS, G. M.: Amino acid transport in established adult rat liver epithelial cell lines. Cell Biol. Toxicol. 2: 9-20, 1986.
7. GEBHARDT, R., BURGER, H. J., HEINI, H., SCHREIBER, K. L. AND MECKE, D.: Alterations of hepatic enzyme levels and of the acinar distribution of glutamine synthetase in response to experimental liver injury in the rat. Hepatology 8: 822-830, 1988.
8. GEBHARDT, R., FITZKE, H., FAUSEL, M., EISENMANN-TAPPE, I. AND MECKE, D.: Influence of hormones and drugs on glutathione-S-transferase levels in primary cultures of adult rat hepatocytes. Cell Biol. Toxicol. 6: 365-378, 1990.
9. GEBHARDT, R., ALBER, J., WEGNER, H. AND MECKE, D.: Different drug metabolizing capacities in cultured periportal and pericentral hepatocytes. Biochem. Pharmacol. 48: 761-766, 1994.
10. GEBHARDT, R., BECKERS, G., FAUSEL, M., GAUNITZ, F., HANIKA, A., HAUPT, W., JONITZA, D., KLEIN, S., PAPKE, M. AND SCHEIJA, L.: (1996). Induction of carbamoylphosphate synthetase and arginase by treatment of cirrhotic rats with L-ornithine-L-aspartate. In Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, E. by C. O. Record and H. Al Mardini, pp. 365-370, MTP Press, Lancaster, 1997.
11. GEBHARDT, R. AND MECKE, D.: Cellular distribution and regulation of glutamine synthetases in liver. In Glutamate Metabolism in Mammalian Tissues, ed. by D. Häussinger and H. Sies, pp. 98-121, Springer Verlag, Heidelberg, 1984.
12. HÄUSSINGER, D.: Nitrogen metabolism in liver: structural, functional organization and physiological relevance. Biochem. J. 267: 281-290, 1990.
13. HÄUSSINGER, D., STEEB, R., KAISER, S., WETTSTEIN, M., STOLL, B. AND GEROK, W.: Nitrogen metabolism in normal and cirrhotic liver. In Cirrhosis, Hepatic Encephalopathy, and Ammonia Toxicity, ed. by S. Grisolia and W. Felapio, pp. 47-64, Plenum Presss, New York, 1990.
14. HÄUSSINGER, D., STEEB, R. AND GEROK, W.: Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. Clin. Invest. 70: 411-115, 1992.
15. HENGLEIN-OTTERMANN, D.: Der Einfluß von Ornithin-Aspartat auf die experimentell erzeugte Hyperammoniämie. Klinisch-experimentelle Studie. Ther. Gegenw. 115: 1504-1518, 1976.
16. HERMANN, G.: Experimentell erzeugte endogene Hyperammoniämien durch Narkotika an der Ratte und deren Beeinflussung durch Ornithin-Aspartat. In Ammoniakstoffwechsel, ed. by I. Szam, pp. 219-223, Schattauer, New York, 1972.
17. JESSY, J., MANS, A. M., DEJOSEPH, M. R. AND HAWKINS, R. A.: Hyperammonemia causes many of the changes found after porto-caval shunting. Biochem. J. 272: 311-317, 1990.
18. KAISER, S., GEROK, W. AND HÄUSSINGER, D.: Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonemia in chronic liver disease. Eur. J. Clin. Invest. 18: 535-542, 1988.
19. KEKOMAKI, M., SCHWARTZ, A. L. AND PENTIKAINEN, P.: Rate of urea synthesis in normal and cirrhotic rat liver with reference to the arginine synthetase system. Scand. J. Gastroenterol. 5: 375-380, 1970.
20. KIRCHEIS, G., QUACK, G. AND ERBLER, H.: L-ornithine-L-aspartate in the treatment of hyperammonemia and hepatic encephalopathy. In Hepatic Encephalopathy: Syndromes and Therapies, ed. by H. O. Conn and J. Bircher, pp. 373-383, Medi-Ed. Press., Bloomington, IL, 1994.
21. KRÄHENBÜHL, S. AND REICHEN, J.: Decreased hepatic glucose production in rats with carbontetrachloride-induced cirrhosis. J. Hepatol. 19: 66-70, 1993.
22. LOCKWOOD, A. H., MCDONALD, J. M., REIMAN, R. E., GELBARD, A. S., LAUGHLIN, J. S., DUFFY, T. E. AND PLUM, F.: The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J. Clin. Invest. 63: 449-460, 1979.
23. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
24. LUND, P. AND WIGGINS, D.: The ornithine requirement of urea synthesis. Biochem. J. 239: 773-776, 1986.
25. MCLEAN, E. K., MCLEAN, A. E. M. AND SUTTON, P. M.: Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br. J. Exp. Pathol. 50: 502-506, 1969.
26. MEIJER, A. J., LAMERS, W. H. AND CHAMULEAU, R. A. F. M.: Nitrogen metabolism and ornithine cycle function. Physiol. Rev. 70: 701-748, 1990.
27. MORRIS, S. M.: Regulation of enzymes of the urea and arginine synthesis. Ann. Rev. Nutr. 12: 81-101, 1992.
28. MÜTING, D. AND RELKOWSKI, J.: Kontrollierte Studie über die Wirkung einer oral verabreichten ammoniaksenkenden Aminosäure Ornithin-Aspartat auf Leber- und Pankreasfunktion bei Leberzirrhosekranken. Therapiewoche 30: 5990-5996, 1980.
29. ORLANDI, F., BRUNELLI, E., BENEDETTI, A. AND MACARRI, G.: clinical trials of nonabsorbable disaccharide therapy in hepatic encephalopathy. In Hepatic Encephalopathy: Syndromes and Therapies, ed. by H. O. Conn and J. Bircher, pp. 209-217, Medi-Ed. Press., Bloomington, IL, 1994.
30. REICHEN, J., ARTS, B., SCHAFROTH, U., ZIMMERMANN, A., ZELTNER, T. B. AND ZYSSET, T.: Aminopyrine N-demethylation by rats with liver cirrhosis: evidence for the intact cell hypothesis: a morphometric-functional study. Gastroenterology 93: 719-726, 1987.
31. REICHEN, J., EGGER, B., OHARA, N., ZELTNER, T. B., ZYSSET, T. AND ZIMMERMANN, A.: Determinants of hepatic functions in liver cirrhosis in the rat: a multivariate analysis. J. Clin. Invest. 82: 2069-2076, 1988.
32. SCHMIDT, E.: Glutamate dehydrogenase, UV-test. In Methoden der Enzymatischen Analyse, vol. 1, 3rd ed., ed. by H. U. Bergmeyer, pp. 689-696, Verlag Chemie, Weinheim, 1974.
33. 4 cirrhosis of rats. Hepatology 9: 373-379, 1989.
34. SNODGRASS, P. J. AND LIN, R. C.: Induction of urea cycle enzymes of rat liver by amino acids. J. Nutr. 111: 586-601, 1981.
35. STAEDT, U., LEWELING, H., GLADISCH, R., KORTSIK, C., HAGMÜLLER, E. AND HOLM, E.: Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J. Hepatol. 19: 424-430, 1993.
36. URIBE, M.: Dietary management of portal-systemic encephalopathy. In Hepatic Encephalopathy: Syndromes and Therapies, ed. by H. O. Conn and J. Bircher, pp. 331-349, Medi-Ed. Press., Bloomington, IL, 1994.
37. ZIEVE, L., LYFTOGT, C. AND RAPHAEL, D.: Ammonia toxicity: comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate, and carbamyl glutamate. Metab. Brain Res. 1: 25-35, 1986.